Meeting
2019 Genitourinary Cancers Symposium
Prognostic and predictive role of comprehensive geriatric assessment (CGA) in elderly patients with metastatic renal cell cancer (RCC) treated with sunitinib (SUN) or pazopanib (PAZ): A single center experience.
Authors
Francesco Pierantoni
Oncologia Medica 1 - Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy
Francesco Pierantoni , Umberto Basso , Marco Maruzzo , Antonella Brunello , Giuseppe Anile , Annunziata Lettiero , Giuseppina Tierno , Evelina Lamberti , Vittorina Zagonel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 37, 2019 (suppl 7S; abstr 647)
DOI
10.1200/JCO.2019.37.7_suppl.647
Abstract #
647
Poster Bd #
H20
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Quality Care Symposium
Comparative effectiveness research in renal cell carcinoma: Lenvatinib with everolimus as a potential new treatment option.
First Author: Gabriel Tremblay
Poster
2023 ASCO Genitourinary Cancers Symposium
The survival outcomes of metastatic non-clear cell renal cell carcinoma in the immunotherapy era: Princess Margaret Cancer Centre (PMCC) experience.
First Author: Esmail Mutahar Al-Ezzi
Poster
2014 ASCO Quality Care Symposium
Reporting on quality indicators in renal cell carcinoma: Proportion of metastatic patients who initially commence on full-dose targeted therapy.
First Author: Lori Wood
Poster
2024 ASCO Genitourinary Cancers Symposium
Role of geriatric assessment and oncological multidimensional prognostic index (Onco-MPI) in a real-world cohort of elderly patients with advanced urothelial carcinoma.
First Author: Davide Bimbatti